Celyad Oncology SA (STU:1C0)

€ 0.678 0.048 (7.62%) Market Cap: 23.32 Mil Enterprise Value: 18.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Half Year 2023 Celyad Oncology SA Earnings Call Transcript
Sep 05, 2023

€0.84 (-21.50%)

Earnings
Q4 2022 Celyad Oncology SA Earnings Call Transcript
Mar 24, 2023

€0.785 (-2.48%)

Earnings
Q2 2022 Celyad Oncology SA Earnings Call Transcript
Aug 05, 2022

€2.1 (+2.19%)

Earnings
Q4 2021 Celyad Oncology SA Earnings Call Transcript
Mar 25, 2022

€2 (-7.29%)

Earnings
Q2 2021 Celyad Oncology SA Earnings Call Transcript
Aug 04, 2021

€3.51 (-1.13%)

Earnings
Celyad Oncology at H C Wainwright Global Life Sciences Conference (Virtual) - On-Demand Presentation Transcript
Mar 09, 2021

Q2 2021 Celyad Oncology SA Earnings Call Transcript

Aug 04, 2021 / 12:00PM GMT

Release Date Price: €3.51 (-1.13%)

Transcript

Operator

Good morning, and welcome to the Celyad Oncology first-half 2021 earnings conference call. (Operator Instructions) Please note this event is being recorded.

I would like to turn the conference over to Dan Ferry, Managing Director with LifeSci Advisors. Please go ahead.

Dan Ferry

LifeSci Advisors, LLC - IR

Thank you all for joining us today. Before we begin, I would like to remind everyone that today's event may contain forward-looking statements within the meaning of the applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks and uncertainties, which may cause actual results, financial condition, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. A list and description of these risks, uncertainties and other risks can be found in the company's US Securities and Exchange Commission filings and reports, including in its annual report on Form 20-F filed with the SEC on March

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.